Supplement: TX HB638 | 2023-2024 | 88th Legislature | Fiscal Note (House Committee Report)
For additional supplements on Texas HB638 please see the Bill Drafting List
Bill Title: Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
Status: 2023-05-11 - Laid on the table subject to call [HB638 Detail]
Download: Texas-2023-HB638-Fiscal_Note_House_Committee_Report_.html
Bill Title: Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
Status: 2023-05-11 - Laid on the table subject to call [HB638 Detail]
Download: Texas-2023-HB638-Fiscal_Note_House_Committee_Report_.html
TO: |
Honorable Stephanie Klick, Chair, House Committee on Public Health |
FROM: |
Jerry McGinty, Director, Legislative Budget Board
|
IN RE: |
HB638 by Toth (relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.), Committee Report 1st House, Substituted |
No significant fiscal implication to the State is anticipated.
It is assumed that any costs associated with the bill could be absorbed using existing resources.
Local Government Impact
No significant fiscal implication to units of local government is anticipated.
Source Agencies: b > td > | 503 Texas Medical Board, 529 Health and Human Services Commission, 537 State Health Services, Department of |
LBB Staff: b > td > | JMc, NPe, ER, APA |